Should You Buy Nike Stock Before Oct. 1?

Nike is due to report fiscal Q1 2027 earnings on Oct. 1 after its shares fell to a 12-year low, nearly 80% below the 2021 peak, and its removal from the S&P 100 earlier in September. Fiscal 2026 revenue was essentially flat at $46.4B, while net income fell 3% to $3.1B; analysts expect revenue to decline another 3% in fiscal Q1 and 2% for fiscal 2027. Although Nike trades at a 17x P/E and yields 4.6%, its $2.4B dividend payout exceeded $2.2B of free cash flow, raising concerns over financial flexibility amid persistent market-share losses.

Analysis

The relevant near-term issue is not the headline valuation but whether management resets the earnings-power trajectory again on Oct. 1. With revenue already under pressure, incremental brand investment, wholesale re-entry incentives, and product-cycle spending can create a two-sided squeeze: lower sell-through leaves gross margin exposed to promotions while the turnaround requires elevated demand creation. That makes consensus downside asymmetric over the next 1-3 months if management cannot quantify improving order trends, inventory quality, and full-price sell-through.

ONON and adidas are not merely share-gain beneficiaries; greater wholesale shelf-space availability raises their brand-discovery and replenishment velocity, potentially improving retailer bargaining power against NKE. The second-order risk for NKE is that restoring distribution may require more favorable retailer economics, structurally lowering its prior direct-to-consumer margin premium. Conversely, a credible recovery in wholesale order books would be more consequential for NKE than a modest quarterly EPS beat, because it would challenge the market's assumption of persistent category-share loss.

The dividend should be viewed as a capital-allocation constraint rather than valuation support. If free cash flow does not recover over the next 6-18 months, preserving payout capacity reduces flexibility for buybacks, marketing, and product investment; any dividend-growth pause would likely trigger another multiple reset among income-oriented holders. Index-related passive selling is largely a completed technical event, so it is a weak standalone bearish catalyst from here.

Consensus bearishness may be crowded into earnings. A low bar creates scope for a sharp tactical rebound if gross margin, inventory, and wholesale commentary show measurable improvement; however, absent evidence of demand stabilization, a one-quarter beat is likely to be sold as cost timing rather than a durable rerating catalyst.

Key Decisions for Investors

• Maintain an underweight/short NKE into Oct. 1 only versus a consumer-discretionary hedge such as XLY or a long adidas position; target a 10-15% relative move over 1-3 months if FY27 revenue or gross-margin guidance is reduced. Cover if management shows improving wholesale orders and maintains or raises full-year margin guidance.
• Prefer long ONON versus short NKE as a 6-12 month share-shift expression. Size modestly: ONON carries a materially higher execution and valuation sensitivity, so the trade requires continued top-line growth and no evidence that NKE is reclaiming premium running shelf space.
• Do not buy NKE solely for yield ahead of earnings. Upgrade to a tactical long only if the report demonstrates sequential improvement in North America/wholesale sell-through, clean inventories, and free cash flow sufficient to cover dividends without balance-sheet deterioration.
• Monitor NKE's next capital-return announcement and quarterly free-cash-flow coverage. A dividend freeze, cut, or renewed debt-funded payout would be a structural bearish catalyst; sustained coverage above 1.2x alongside revenue stabilization would falsify the cash-flow bear case.